Vedolizumab associated haematochezia: A disproportionality analysis in USFDA adverse event reporting system database

被引：0
|
作者：
Bellapu, Anusha [1 ]
Viswam, Subeesh K. [1 ]
Sharma, Vasista [1 ]
Chacko, Stephy T. [1 ]
机构：
[1] MS Ramaiah Univ Appl Sci, Bangalore, Karnataka, India
来源：
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY | 2020年 / 29卷
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
4307
引用
收藏
页码：464 / 464
页数：1
相关论文
共 50 条
  • [21] Vedolizumab Adverse Events: Analysis of the FDA Adverse Event Reporting System
    Jow, Steven
    Hutfless, Susan
    [J]. INFLAMMATORY BOWEL DISEASES, 2017, 23 : S35 - S36
  • [22] Cardiovascular adverse events associated with parp inhibitors: A disproportionality analysis of FDA adverse event reporting system
    Viswam, Subeesh Kulangara
    Kheterpal, Aarushi
    Dhas, Ashwin
    Zeba, Zeba
    Shettigar, Amrutha
    Lukose, Lipin
    Kaur, Gursimran
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2022, 31 : 452 - 452
  • [23] LURASIDONE INDUCED SUICIDAL IDEATION AND HALLUCINATION: DISPROPORTIONALITY ANALYSIS IN FDA ADVERSE EVENT REPORTING SYSTEM DATABASE
    Pudi, C.
    Subeesh, V
    Maheswari, E.
    Koonisetty, K. S.
    [J]. VALUE IN HEALTH, 2018, 21 : S277 - S277
  • [24] Weight gain, gender, and antipsychotics: a disproportionality analysis of the FDA Adverse Event Reporting System database (FAERS)
    Stamoula, Eleni
    Stamatellos, Vasileios-Periklis
    Vavilis, Theofanis
    Dardalas, Ioannis
    Papazisis, Georgios
    [J]. EXPERT OPINION ON DRUG SAFETY, 2024, 23 (02) : 239 - 245
  • [25] Hypnotics and infections: disproportionality analysis of the US Food & Drug Administration adverse event reporting system database
    Meng, Long
    Huang, Jing
    He, Qin
    Zhao, Yibei
    Zhao, Wenlong
    Tan, Juntao
    Sun, Shusen
    Yang, Junqing
    [J]. JOURNAL OF CLINICAL SLEEP MEDICINE, 2022, 18 (09): : 2229 - 2235
  • [26] ASSOCIATION OF USTEKINUMAB WITH CARPAL TUNNEL SYNDROME, CUTANEOUS LUPUS ERYTHEMATOSUS, BASEDOW'S DISEASE AND MELANOCYTIC NAEVUS: A DISPROPORTIONALITY ANALYSIS IN USFDA ADVERSE EVENT REPORTING SYSTEM DATABASE
    Vajapu, M.
    Das, A.
    [J]. VALUE IN HEALTH, 2023, 26 (06) : S171 - S171
  • [27] A disproportionality analysis of sunitinib in the FDA adverse event reporting system (FAERS)
    Zou, Wenbin
    Yang, Han
    Xi, Yu
    Zeng, Chenxi
    Chen, Wei
    Fu, Xiangning
    [J]. HELIYON, 2024, 10 (17)
  • [28] Proarrhythmia associated with antiarrhythmic drugs: a comprehensive disproportionality analysis of the FDA adverse event reporting system
    Wang, Feifei
    Zhou, Bingfeng
    Sun, Hongwei
    Wu, Xinan
    [J]. FRONTIERS IN PHARMACOLOGY, 2023, 14
  • [29] 'Extreme duplication' in the USFDA adverse events reporting system database
    Reich, Lester
    [J]. DRUG SAFETY, 2007, 30 (06) : 551 - 554
  • [30] Facial Paralysis Following Influenza Vaccination: A Disproportionality Analysis Using the Vaccine Adverse Event Reporting System Database
    Ashwin Kamath
    Nivedita Maity
    Manel Arjun Nayak
    [J]. Clinical Drug Investigation, 2020, 40 : 883 - 889
12345